'The Global Advanced Wound Care Market Will be Worth $16.3bn by 2023' Says Visiongain Report

LONDON, December 10, 2012 /PRNewswire/ --

A new report by visiongain, a London-based business information provider predicts the global advanced wound care market to be worth $16.3bn by 2023. The market generated $6.5bn in 2011, according to Advanced Wound Care: World Market Prospects 2013-2023, published in November 2012. Clinicians and patients now prefer advanced products over the traditional ones, as they are more efficient in wound healing and reducing hospital stays. The advanced wound care market is expected to achieve strong growth in the future, driven by an aging population, and increasing prevalence of diabetes and obesity leading to more chronic wounds.

Amritha.M.Ramakrishnan, healthcare industry analyst says "The advanced wound care products have become physicians' preferred choice for treatment of chronic wounds. New product launches, increased penetration of existing products into developing countries and technological advancements will drive future growth. In the recent years, advanced wound care products have enjoyed strong growth mainly driven by moist wound care products and to a small extent by wound care devices and biologics. Most of the research is now being focused on wound care devices and biologics, as the moist wound care market is saturated. Wound care devices, particularly NPWT have a strong place in the advanced wound care market. However, further growth in this market will be driven by low cost and easy to use models. At present, wound care biologics is the most immature market. Although, some of the biologic products have proven to be more effective than other treatment methodologies, the cost to the consumer and lack of clinical evidence are major issues. With the advanced wound care market becoming more and more competitive, the market will be driven by more cost effective and clinically significant products".

Visiongain's research suggests that the advanced wound care market will also benefit from the growth of emerging economies. Countries including China and India are already witnessing an increase in lifestyle related disorders such as diabetes and obesity, along with increasing spending power. In the near future, mature markets such as the US and EU will drive the adoption of novel wound care devices and biologics, which command high prices in the market. Wound care biologics are still to achieve the attention they deserve, since the high cost of treatment has prevented their wide scale use. However, the market for wound care biologics will witness strong growth as their cost-effectiveness becomes evident.

Visiongain's analysis of the moist wound care, wound care devices and wound care biologics pipelines shows a number of innovative products with a great deal of promise. This new report adds to visiongain's wide range of analytical reports in healthcare and other industry areas.

For sample pages and further information concerning the visiongain Advanced Wound Care: World Market Prospects 2013-2023 report please visit: http://www.visiongain.com/Report/940/Advanced-Wound-Care-World-Market-Prospects-2013-2023

Companies Listed
3M
Acell
AcryMed
Activa Health Care
Advanced Medical Solutions
Agennix
Anika Therapeutics
AOTI
Argentum Medical
ArjoHuntleigh
Armed Forces Institute of Regenerative Medicine (AFIRM)
Arobella Medical
Avita Medical
Biofisica
Biolight AB
B.Braun
Boehringer Ingelheim
Brennen Medical
BSN Medical Gmbh
Cardium Therapeutics
Catrix
Celleration
Centre for Devices and Radiological Health (CDRH)
Collagen Matrix
Coloplast
ConvaTec
Cornell University
Covalon Technologies
Covidien
Curatec
Curasan
Cytomedix
Derma Sciences
Deroyal
Devon Medical Products
Diapulse Corporation of America
Dr. Suwelack Skin & Healthcare
Dow-Hickam
Eucare Pharmaceuticals
Ferris
Fibrogen
Fidia Advanced Biopolymers
Food and Drug Administration (FDA)
Forticell Bioscience
Fraunhofer Institute
Garnet Biotherapeutics
Genadyne Biotechnologies
Genzyme Biosurgery
Getinge
Greystone Pharmaceuticals
Hartmann Group
Healthpoint Biotherapeutics
HemCon Medical Technologies
Hollister Wound Care
Human Biosciences
HydroFera
Innovative Therapies
Ingenious Technologies Corporation
Integra Life Science Corp
International Diabetic Federation (IDF)
Innocoll
Italian National Health Service
IYIA Technologies
Johnson & Johnson
Kaken Pharmaceuticals
Kalypto Medical
Kinetic Concepts
Kuros Biosurgery
Lifecell
Lightwave Technologies
Lescarden
Lohmann & Rauscher
Macrocure
Marine Polymer Technologies Inc
McGowan Institute for Regenerative Medicine
Medestea Internazionale
MediWound
Medline Industries
MiMedX
Ministry of Health, Labour and Welfare (MHLW)
Misonix
Missouri S&T and Mo-Sci Corporation
Molnlycke
Nara University, Japan
National Competent Authorities (NCA)
National Health Service (NHS)
Nanotherapeutics
NanoVibronix
Noble Biomaterials
Oculus Innovative Sciences
Organogenesis
Osiris Therapeutics
Oxygen Biotherapeutics
Phytoceuticals
Polyheal
Polynovo Biomaterials
Promethean LifeSciences
Prospera
Quick Med Technologies
RedDress
RegeneRx Biopharmaceuticals
Regenesis Biomedical
SafeBlood Technologies
Sangui BioTech International
Sanuwave Health
Shire Regenerative Medicine
Smith & Nephew
Soring
Spiracur
Synapse Microcurrent
Snyder Wound Research LLC
Systagenix
Talley Group
Tissue Genesis
Tissue Regeneration Technologies
UC, Berkley
UDL Laboratories
ULURU
United Nations (UN)
University of Cincinnati
University of Bath
URGO
Vibrant Medical
Vario
Vomaris Innovations
Wellman Centre for Photomedicine, Harvard University
Wound Management Technologies
Wright Medical

About visiongain

Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

For an executive summary please contact: Sara Peerun, sara.peerun@visiongainglobal.com, Tel: +44(0)20-7336-6100